You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. AAV2-ASPA-Based Metabolic Intervention for Alzheimer's Disease

    SBC: ASKLEPIOS BIOPHARMACEUTICAL, INC.            Topic: NIA

    Abstract We propose to initiate preclinical development of a gene therapeutic targeted to Alzheimer's Disease. The World Health Organization's and Alzheimer's Disease International's report on Dementia (2012) recognizes that the global burden of AlzheimerDisease is forecast to worsen significantly with prevalence predicted to double every 20 years. Interventions that could prov ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. A Coaxial High Energy Thruster for Defensive Space Applications

    SBC: BUSEK CO., INC.            Topic: AF07T036

    Busek Co. Inc. and Stanford University propose to develop and test an advanced high power plasma propulsion concept referred to here as a Coaxial High EnerGy Thruster, or CHENG thruster.  The thruster is first and foremost a propulsive device.  However, because the device is pulsed, compact, and efficient the plasma beam is highly condensed and energetic. For this reason, the thruster may also b ...

    STTR Phase II 2009 Department of DefenseAir Force
  3. Advanced infrared laser fibers

    SBC: AGILTRON, INC.            Topic: AF07T037

    This program will demonstrate, for the first time, a commercial prototype high power fiber laser in the 3-5µm band, based on Agiltron chalcogenide glass infrared optical fiber technology. High power IR lasers that emit multiwatt output at various infrared wavelengths in the 212µm region are a long-standing technical challenge. Fiber lasers, widely considered the choice for almost all high power ...

    STTR Phase II 2009 Department of DefenseAir Force
  4. Advanced Window Materials for High Energy Propulsion

    SBC: CERANOVA CORP            Topic: AF07T009

    CeraNova transparent polycrystalline alumina - advanced window materials for high energy propulsion.  High total transmission in the visible and the MWIR.  Submicron grains result in high hardness and strength.  High chemical resistance, thermal shock resistance, impact and erosion resistance.  Powder processing enables cost effective near-net shaping of curved parts.  Proprietary technology ...

    STTR Phase II 2009 Department of DefenseAir Force
  5. A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors

    SBC: ARISAPH PHARMACEUTICALS, INC.            Topic: 102

    DESCRIPTION provided by applicant Cancer is the second leading cause of death after heart disease in the US Chemotherapy is a mainstay of treatment after surgical removal of tumors but the balance of clinical benefit versus disabling or life threatening side effects is often uncertain Genotyping of cancers to identify mutated oncogenes has enabled an era of targeted therapy Drugs targeting ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. An Acoustic Mobility Aid for the Visually Impaired

    SBC: BIOMIMETIC SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this project is to develop a sonar system that can be used as a mobility aid by the visually impaired. The system will consist of an ultrasonic acoustic source using a waveform that is designed to optimize target discrimination and a pair of miniature microphones that are mounted near the ears to create natural interaural level and timing difference ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  7. A Nanofibrous Bioactive Prosthetic Sewing Cuff

    SBC: BIOSURFACES INC            Topic: N/A

    DESCRIPTION (provided by applicant): Cardiac valve replacement using prosthetic valves is indicated when progression of degenerative disease or bacterial infection of the native valve results in valvular dysfunction, thereby impacting on cardiac output. An estimated 50,000 prosthetic valves are implanted annually in the United States, with this number increasing due to an aging population and, to ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  8. A Novel Drug for Septicemia Targets A1 ARs

    SBC: ENDACEA, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Despite the availability of newer antimicrobial agents, improved supportive care, and the introduction of an FDA approved adjunctive therapy for sepsis, (Xigris(r), drotrecogin alfa), the mortality rate for severe sepsis and septic shock of 30-60% remains high. Endacea, Inc. (Research Triangle Park, NC) approaches sepsis with a proprietary diagnostic/biomarker ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  9. A novel therapeutic approach for Acute Lung Injury/ARDS

    SBC: BIOMARCK PHARMACEUTICALS, LTD            Topic: NHLBI

    DESCRIPTION (provided by applicant): The objective of the proposed project is to advance the development of novel peptides targeting MARCKS (Myristoylated Alanine-Rich C Kinase Substrate) protein as platform drug molecules for the treatment of Acute Lung Injury (ALI) and its more severe form, Acute Respiratory Distress Syndrome (ARDS), thereby providing the first pharmacologic therapeutic for this ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. A Novel Therapy for Staphylococcal Enterotoxin B Poisoning

    SBC: SOYMEDS INC            Topic: N/A

    DESCRIPTION (provided by applicant): Staphylococcus aureus is a significant human pathogen which can produce a variety of toxins, including the exotoxin, staphylococcal enterotoxin B (SEB). SEB is highly toxic in small doses, and the compact structure of this protein makes it resistant to heat and denaturation. The combination of toxicity and stability caused this toxin to be selected for weaponiz ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government